VISIT NUTRACEUTICALS WORLD AT STAND E178

Lesaffre to Highlight Ingredients for Women’s Health

05.08.17

Company offers product range backed by strong science.

Booth I32
 
Lesaffre Human Care, supplier of quality ingredients from yeast and bacteria fermentation for the global human care markets, will be presenting Lynside VAGINACTIV, its new range of ingredients dedicated to women’s health at Vitafoods Europe Booth I32.
 
As of now, the range includes two unique and completely natural solutions that have demonstrated efficacy on vaginal health in recent studies. Lesaffre Human Care’s healthy yeasts have indeed proven their ability to fight pathogenic yeast Candida albicans, prominent cause of vaginal infections.
 
Vulvovaginal candidiasis is in fact one of the most prevalent causes of vaginal infections in women of reproductive age and is characterized by the disruption of the vaginal microbiota composition. This unbalance favors opportunistic pathogen Candida albicans overgrowth. With over 75% of women worldwide experiencing at least one episode of vulvovaginal candidiasis in their life, 4 to 8% of whom suffering from recurrence (4 or more per year), Lesaffre Human Care’s dedicated range, Lynside VAGINACTIV, provides natural and innovative solutions to get rid of C. albicans and prevent recurrence.
 
The company offers two distinct ingredients for day-to-day support to deliver long term results:
 
  • Lynside VAGINACTIV Oral: a unique probiotic yeast (Saccharomyces cerevisiae CNCM I-3856) designed for oral use;
  • Pharma VAGINACTIV Local: a specific dried yeast (Saccharomyces cerevisiae CNCM I-3856) designed for medical devices for vaginal application and certified Active Pharmaceutical Ingredient (API)
 
Offering different responses to a common challenge, these two ingredients can be used individually or concomitantly to fight vaginal infections and prevent recurrence.
 
These two yeasts recently received attention from the scientific community and notably from Dr. Duncan Wilson, research fellow at the University of Aberdeen (U.K.), who wrote about their positive influence on the course of vaginal candidiasis. In a paper published in Virulence, researchers also discuss how the post-challenge administration of living yeast S. cerevisiae CNCM I-3856 or dried yeast was able to accelerate the clearance of C. albicans in an experimental model of vulvo-vaginal candidiasis. Both were found to induce coaggregation with the pathogen allowing its fast elimination. Lynside VAGINACTIV Oral was also able to suppress major virulence factors of C. albicans.
 
Vitafoods, will also be the occasion for Lesaffre Human Care to feature Lynside ProteYn, the first yeast protein on the market, officially launched at HIE last year. Containing all essential amino acids, including branched-chain amino acids, Lynside ProteYn is a complete protein, ideal for people looking to enhance their protein intake with non-animal protein sources. Lesaffre Human Care yeast proteins are in fact characterized by an excellent chemical score and Protein Digestibility–Corrected Amino Acid Score (PDCASS[1]), respectively above 100% and greater than 1, which is similar to dairy protein and much higher than all plant-based proteins.
 
Beside offering a complete high-profile aminogram and high digestibility score, Lynside ProteYn ingredients are also packed with micronutrients such as naturally-occurring fibers, B vitamins and minerals such as iron, zinc, calcium, magnesium, phosphorus and potassium. This can prove to be a very valuable asset for people such as vegan, vegetarians of flexitarians, who are at increased risk of vitamin and mineral deficiency.
 
Building upon the notoriety of nutritional yeasts as well as the company’s 160 years of experience in yeast development, Lesaffre Human Care yeast proteins are designed to resonate with modern consumers who are looking for nutrient-packed food they can trust. Lynside ProteYn is non-GMO, allergen-free (gluten, dairy and soy-free) and free from anti-nutritional factors such as protease inhibitors, phytates, etc. Consumers can also rest assured that Lesaffre Human Care’s yeast protein have been produced without pesticides or antibiotics for growth.
 
Thanks to a very specific manufacturing process, Lynside ProteYn also benefits from having a low environmental impact (low water consumption, reduced carbon footprint, quick turnaround, etc.). It can therefore be considered as a sustainable protein, in comparison to other more resource-intensive and environmentally impactful options.
 
In light of the recent publication of a meta-analysis confirming ibSium’s efficacy in managing symptoms of gastrointestinal disorders, and notably abdominal pain and discomfort which are considered to be the main problem, Lesaffre Human Care will also be promoting the ingredient at the show. Performed on the data collected during two previous randomized clinical trials, studying the effect of a daily supplementation of ibSium in a total of 579 healthy subjects, this individual patient data meta-analysis not only strengthens previous conclusions on the ingredient’s capacity to alleviate gastrointestinal pain and discomfort, but is also a recognition of the company’s long-term investment in providing strong scientific and clinical data to substantiate the health benefits of its patented ingredients.